Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
Pfizer
Pfizer
Bristol-Myers Squibb
Multiple Myeloma Research Foundation
Regeneron Pharmaceuticals
Celgene
CARsgen Therapeutics Co., Ltd.
Duke University
AbbVie
University of California, San Francisco
Centre Hospitalier Universitaire de Saint Etienne
Genesis Pharma S.A.
PETHEMA Foundation
Celgene
Vanderbilt-Ingram Cancer Center
Vanderbilt University Medical Center
Karolinska University Hospital
Columbia University
Mayo Clinic